P2X7 Receptor Antagonists Market
- 2026 年市場規模
- USD 135.2 Mn
- 2033 年預估規模
- USD 438 Mn
- 年複合成長率 CAGR
- 18.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
P2X7 Receptor Antagonists Market, By Drugs (AKP-23494954/RQ-00466479, EVT 401, GSK1482160, JNJ-55308942, JNJ-54175446, and Others (e.g.- AZ11657312)), By Application (Central Nervous System Disorders, Immunological Disorders, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
P2X7 receptor antagonists are still in the developmental stage and will require regulatory approval for introduction into the market. Manufacturers need to file an Investigational New Drug Application (IND) with the U.S. Food & Drug Application (FDA). Every drug is required to go through the approval process set by the FDA. P2X7 antagonists will be going through all the clinical trials after filing an Investigational New Drug (IND) application as any other new drug. However, the pharmaceutical organizations face several challenges for introducing these medications in the market due to a stringent regulatory approval process. These factors are considered in global P2X7 receptor antagonist market and factors affecting global P2X7 receptor antagonist market growth.
Market Dynamics
P2X7 Receptor Antagonists drug category is highly lucrative, as no drug therapies are available in this category. Leading organizations are investing in research and development of drugs in this category, which is expected to help market players in generating high revenue using patent protection. Disease and conditions such as major depressive disorders, mood disorders, chronic pain, and inflammation are highly prevalent and their incidence is also increasing. According to National Health Service Digital (NHS Digital), U.K., antidepressants medications prescriptions observed the largest increase in 2016, indicating the prevalence of depressive disorders. If launched, P2X7 receptor antagonists will be capable of acquiring a significant amount of market share for the disease or indication for which they have been approved. Drug manufacturers are also advancing the P2X7 antagonist drug category by developing innovative drugs such as AKP-23494954/RQ-00466479 (Asahi Kasei/RaQualia Pharma). These factors are expected to support global P2X7 receptor antagonist market growth over the forecast period.
Key features of the study
• This report provides in-depth analysis of the P2X7 receptor antagonists market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global P2X7 receptor antagonists market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include, Asahi Kasei Corporation, GlaxoSmithKline Plc, Johnson & Johnson, AstraZeneca Plc, Evotec AG, and RaQualia Pharma
• Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
• The global P2X7 receptor antagonists market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the P2X7 receptor antagonists market
Market Segmentation
• Drugs Insights (Revenue, USD Mn, 2026 - 2033)
o AKP-23494954/RQ-00466479
o EVT 401
o GSK1482160
o JNJ-55308942
o JNJ-54175446
o Others (e.g.- AZ11657312)
• Application Insights (Revenue, USD Mn, 2026 - 2033)
o Central Nervous System Disorders
o Immunological Disorders
o Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o GlaxoSmithKline Plc
o Johnson & Johnson
o AstraZeneca Plc
o RaQualia Pharma
o Evotec AG
o Asahi Kasei Corporation
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drugs
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Pipeline Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
o Key Developments
o PEST Analysis
o Epidemiology
4. Global P2X7 Receptor Antagonists Market, By Drugs, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o AKP-23494954/RQ-00466479
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o EVT 401
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o GSK1482160
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o JNJ-55308942
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o JNJ-54175446
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others (e.g.- AZ11657312)
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global P2X7 Receptor Antagonists Market, By Application, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Central Nervous System Disorders
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Immunological Disorders
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global P2X7 Receptor Antagonists Market, By Region, 2026–2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Drugs, 2026- 2033, (USD Mn)
Market Size and Forecast, By Application, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Company Profiles
Asahi Kasei Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
GlaxoSmithKline Plc
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
AstraZeneca Plc
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Evotec AG
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
RaQualia Pharma
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們